Our clinical trials program is bringing the world’s best treatments to patients with eye diseases.
Clinical trials confirm whether new medicines and treatments are safe and effective to introduce as new treatments for a particular disease or condition.
At the Queensland Eye Institute we are committed to supporting initiatives that improve health outcomes for patients with eye disease including improved access to new drugs that may be more effective than those currently available.
Our current clinical trials include:
Thyroid Eye Disease: recruitment open
Ongoing Studies – recruitment closed:
Stargardt Disease
Geographic atrophy (GA) associated with age-related macular degeneration (AMD)
Retinitis pigmentosa (RP) associated with Usher Syndrome